TransGlobal Assets Inc. (TMSH)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Oct 27, 2025, 11:47 AM EDT
TransGlobal Assets Market Cap
TransGlobal Assets has a market cap or net worth of $343.41 thousand as of October 27, 2025. Its market cap has decreased by -30.49% in one year.
Market Cap
343.41K
Enterprise Value
n/a
Revenue
91.35K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since March 11, 2008, TransGlobal Assets's market cap has decreased from 7.54M to 343.41K, a decrease of -95.45%. That is a compound annual growth rate of -16.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 343.41K | -5.18% |
| Dec 30, 2024 | 362.18K | 4.39% |
| Dec 29, 2023 | 346.93K | 6.46% |
| Dec 30, 2022 | 325.89K | -78.28% |
| Dec 31, 2021 | 1.50M | -11.89% |
| Dec 31, 2020 | 1.70M | -33.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 670.91M |
| Glass House Brands | 619.92M |
| Northwest Biotherapeutics | 371.21M |
| Silence Therapeutics | 344.81M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 327.16M |
| American Oncology Network | 291.52M |